116 related articles for article (PubMed ID: 3082834)
1. Augmentation by bacterial lipopolysaccharide of antitumor potency of murine recombinant interferon-gamma against Lewis lung adenocarcinoma.
Nagao S; Sato K; Ogawa H; Osada Y
Jpn J Cancer Res; 1986 Feb; 77(2):212-8. PubMed ID: 3082834
[TBL] [Abstract][Full Text] [Related]
2. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
Hori K; Ehrke MJ; Mace K; Mihich E
Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of cytotoxicity in macrophages by murine interferon-gamma and biological response modifiers derived from microorganisms.
Nagao S; Sato K; Osada Y
Cancer Immunol Immunother; 1986; 23(1):41-5. PubMed ID: 3094943
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
Chen L; Suzuki Y; Wheelock EF
J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state.
Lane TE; Wu-Hsieh BA; Howard DH
Infect Immun; 1993 Apr; 61(4):1468-73. PubMed ID: 8454351
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma or BCG restores the responsiveness of mouse lung macrophages to lipopolysaccharide.
Tokunaga T; Akagawa KS
Tokai J Exp Clin Med; 1986; 11 Suppl():89-96. PubMed ID: 3132756
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
9. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore.
Akagawa KS; Kamoshita K; Onodera S; Tokunaga T
Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284
[TBL] [Abstract][Full Text] [Related]
10. Lipid A-associated proteins provide an alternate "second signal" in the activation of recombinant interferon-gamma-primed, C3H/HeJ macrophages to a fully tumoricidal state.
Hogan MM; Vogel SN
J Immunol; 1987 Dec; 139(11):3697-702. PubMed ID: 3119714
[TBL] [Abstract][Full Text] [Related]
11. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.
Ding AH; Nathan CF; Stuehr DJ
J Immunol; 1988 Oct; 141(7):2407-12. PubMed ID: 3139757
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
13. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
14. Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease.
Black PL; Phillips H; Tribble HR; Pennington R; Schneider M; Talmadge JE
J Cell Biochem; 1988 Apr; 36(4):377-92. PubMed ID: 3132467
[TBL] [Abstract][Full Text] [Related]
15. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
16. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
Stuehr DJ; Marletta MA
J Immunol; 1987 Jul; 139(2):518-25. PubMed ID: 3110273
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
Kondo H; Tanaka N; Naomoto Y; Orita K
Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
[TBL] [Abstract][Full Text] [Related]
18. Effects of bacterial lipopolysaccharide on protein synthesis in murine peritoneal macrophages: relationship to activation for macrophage tumoricidal function.
Hamilton TA; Jansen MM; Somers SD; Adams DO
J Cell Physiol; 1986 Jul; 128(1):9-17. PubMed ID: 3087999
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
